The Australian market recently faced challenges with rising inflation and mixed sector performance, impacting investor sentiment. Despite these hurdles, there remains potential for growth in certain areas of the market. Penny stocks, though an older term, continue to attract attention as they represent smaller or emerging companies that can offer value when backed by solid financials and growth prospects.
Top 10 Penny Stocks In Australia
| Name | Share Price | Market Cap | Rewards & Risks |
| Alfabs Australia (ASX:AAL) | A$0.49 | A$140.43M | ✅ 4 ⚠️ 3 View Analysis > |
| EZZ Life Science Holdings (ASX:EZZ) | A$2.21 | A$104.25M | ✅ 2 ⚠️ 2 View Analysis > |
| Dusk Group (ASX:DSK) | A$0.79 | A$49.19M | ✅ 4 ⚠️ 2 View Analysis > |
| IVE Group (ASX:IGL) | A$2.73 | A$421.37M | ✅ 4 ⚠️ 3 View Analysis > |
| MotorCycle Holdings (ASX:MTO) | A$3.32 | A$245.04M | ✅ 4 ⚠️ 2 View Analysis > |
| Veris (ASX:VRS) | A$0.072 | A$37.28M | ✅ 4 ⚠️ 2 View Analysis > |
| West African Resources (ASX:WAF) | A$3.04 | A$3.47B | ✅ 4 ⚠️ 1 View Analysis > |
| Praemium (ASX:PPS) | A$0.755 | A$360.67M | ✅ 5 ⚠️ 2 View Analysis > |
| Service Stream (ASX:SSM) | A$2.34 | A$1.43B | ✅ 3 ⚠️ 1 View Analysis > |
| MaxiPARTS (ASX:MXI) | A$2.34 | A$129.97M | ✅ 3 ⚠️ 2 View Analysis > |
Click here to see the full list of 427 stocks from our ASX Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Bubs Australia (ASX:BUB)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Bubs Australia Limited, with a market cap of A$138.59 million, manufactures and sells infant and adult chilled and powdered goat dairy products in Australia, China, the United States, and internationally.
Operations: The company's revenue is primarily derived from its food processing segment, which generated A$102.54 million.
Market Cap: A$138.59M
Bubs Australia Limited, with a market cap of A$138.59 million, has recently achieved its first profit and became cash flow positive in FY25, reporting sales of A$102.54 million. The company's financial health is bolstered by being debt-free and having sufficient short-term assets to cover liabilities. Despite these strengths, an auditor expressed concerns about Bubs' ability to continue as a going concern. Leadership changes include the appointment of Joe Coote as CEO, who brings significant experience in the FMCG sector and aims to expand Bubs' international presence amid strategic transformations initiated under former Chair Katrina Rathie.
- Take a closer look at Bubs Australia's potential here in our financial health report.
- Examine Bubs Australia's earnings growth report to understand how analysts expect it to perform.
Clover (ASX:CLV)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Clover Corporation Limited focuses on producing, refining, and selling natural oils and encapsulated powders across various regions including Australia, New Zealand, Asia, Europe, the Middle East, and the Americas with a market cap of A$108.55 million.
Operations: No specific revenue segments have been reported for Clover Corporation Limited.
Market Cap: A$108.55M
Clover Corporation Limited, with a market cap of A$108.55 million, has shown impressive financial performance by reporting sales of A$86 million and net income of A$7.02 million for the year ended July 31, 2025. The company's debt is well-covered by operating cash flow and it holds more cash than total debt, reflecting strong financial health. Clover's earnings growth of 363% over the past year surpasses industry averages, although its return on equity remains low at 9.7%. Recent board changes include Fiona Pearse's appointment as Non-Executive Director, enhancing governance with her extensive commercial expertise.
- Unlock comprehensive insights into our analysis of Clover stock in this financial health report.
- Gain insights into Clover's future direction by reviewing our growth report.
Havilah Resources (ASX:HAV)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Havilah Resources Limited, with a market cap of A$74.85 million, is involved in the exploration and evaluation of mineral resource properties in Australia.
Operations: Havilah Resources Limited currently does not report any specific revenue segments.
Market Cap: A$74.85M
Havilah Resources Limited, with a market cap of A$74.85 million, is pre-revenue and focuses on mineral exploration in Australia. The company maintains a stable financial position with short-term assets of A$25.3 million exceeding both short-term and long-term liabilities, while being debt-free. Recent drilling at the Johnson Dam prospect yielded high-grade uranium results, reinforcing its geological model and potential for future resource delineation. However, challenges like drillhole positioning due to cultural heritage constraints were noted. Havilah's experienced management team supports strategic decision-making as it navigates these operational complexities amidst limited revenue generation.
- Dive into the specifics of Havilah Resources here with our thorough balance sheet health report.
- Assess Havilah Resources' previous results with our detailed historical performance reports.
Taking Advantage
- Investigate our full lineup of 427 ASX Penny Stocks right here.
- Want To Explore Some Alternatives? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Clover might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com